When was Ginkgo Bioworks founded?

Ginkgo Bioworks was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is Ginkgo Bioworks located?

Ginkgo Bioworks is headquartered in Boston, United States. It is registered at Boston, Massachusetts.

Who is the current CEO of Ginkgo Bioworks?

Jason Kelly of Ginkgo Bioworks. They have also founded 2 companies.

How many employees does Ginkgo Bioworks have?

As of Mar 31, 2026, the latest employee count at Ginkgo Bioworks is 638.

Is Ginkgo Bioworks a funded company?

Ginkgo Bioworks is a funded company, having raised a total of $796M across 20 funding rounds to date. The company's 1st funding round was a $100K Grant (prize money) round, raised on Jun 01, 2009.

When was the latest funding round of Ginkgo Bioworks?

Ginkgo Bioworks' latest funding was a Grant (prize money) round on Dec 13, 2023, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.84B in funding in 2026 to date.

Is Ginkgo Bioworks a Genomics company?

The primary sectors of Ginkgo Bioworks are Genomics and Crop Tech.

Where does Ginkgo Bioworks rank among its competitors?

Ginkgo Bioworks ranks 1st amongst 1941 active competitors, of which 226 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Kula Bio, which secured $15.5M in Nov, 2025.

Who are the top competitors of Ginkgo Bioworks?

Ginkgo Bioworks' top competitors include Indigo, Syngenta and Spark Therapeutics. Among them, Kula Bio secured the most recent funding round in November, 2025.

Ginkgo Bioworks - 2026 Company Profile, Team, Funding & Competitors

Ginkgo Bioworks is a public company based in Boston (United States), founded in 2008 by Tom Knight, Reshma Shetty, Austin Che and Jason Kelly. It operates as an Autonomous labs for biotechnology, empowering scientists to design the living world. Ginkgo Bioworks has raised $796M in funding from investors like Viking Global Investors, Illumina and Felicis Ventures. The company has 1941 active competitors, including 226 funded and 160 that have exited. Its top competitors include companies like Indigo, Syngenta and Spark Therapeutics.

Sectors and market segments that Ginkgo Bioworks operate in

Ginkgo Bioworks serves in the Life Sciences, Food and Agriculture Tech market segments.The primary business model of Ginkgo Bioworks are:

Company Details

Autonomous labs for biotechnology, empowering scientists to design the living world. They provide autonomous labs and cloud lab services, enabling scientists to automate experimental work and focus on insight and creativity. The company offers solutions and datapoints services to design experiments and address research goals. Their autonomous systems lift the burden of manual lab work, empowering scientists to ask critical questions. They provide hardware, software, support, and cloud lab resources. The company's vision is to enable programming biology, curing diseases, and growing everything imaginable. This is a B2B tech company offering SaaS solutions for biotechnology and pharmaceutical industries.

Website: ginkgobioworks.com
Social
Email ID: *****@ginkgobioworks.com
Phone Number: +1 **********
Registered Address: Boston, Massachusetts

Key Metrics

Founded Year

2008

Location

Boston, United States

Stage

Public

Total Funding

$796M in 20 rounds

Latest Funding Round

Grant (prize money), Dec 13, 2023, Undisclosed

Investors

Viking Global Investors & 54 more

Ranked

1^st among 1941 active competitors

Employee Count

638 as on Mar 31, 2026

Investment & Acquisitions

Patch & 16 more

Similar Companies

Syngenta & 333 more

Exit Details

Public

View Ginkgo Bioworks' full profile

Ginkgo Bioworks is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Ginkgo Bioworks, Inc. CIN: 263118890 , United States, Active	Dec 26, 999	-	836 (As on Dec 31, 2024)	-
GINKGO BIOWORKS HOLDINGS, INC. CIN: 1830214 , United States, Active	Sep 14, 2021	$100M - $500M (As on Dec 31, 2025)	-	-
Ginkgo CIN: 40203083488 , Latvia, Active	Jul 26, 2017	€0 - €1M (As on Dec 31, 2024)	1 (As on Dec 31, 2023)	-

Ginkgo Bioworks got listed on Sep 17, 2021.

Click here to take a look at Ginkgo Bioworks's IPO in detail

Ginkgo Bioworks has raised a total funding of $796M over 20 rounds. Its first funding round was on Jun 01, 2009. Its latest funding round was a Grant (prize money) round on Dec 13, 2023 for an undisclosed amount. 1 investor participated in its latest round. Ginkgo Bioworks has 52 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Ginkgo Bioworks:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 13, 2023	Undisclosed	Grant (prize money)	-	-	-	Gates
Aug 03, 2023	$387K	Grant (prize money)	-	-	-	HHS
Jun 01, 2023	$650K	Grant (prize money)	-	-	-	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of Ginkgo Bioworks's funding rounds and investors

The founders of Ginkgo Bioworks are Tom Knight, Reshma Shetty, Austin Che and Jason Kelly. Jason Kelly is the CEO of Ginkgo Bioworks.

Here are the details of Ginkgo Bioworks' key team members:

Tom Knight: Co-Founder of Ginkgo Bioworks. They are also an angel investor in 2 startups.
Contact Info: 1 email address
Reshma Shetty: Co-Founder of Ginkgo Bioworks and founder of 3 other companies, Ginkgo, Pillar VC and Petri.
Contact Info: 1 email address
Austin Che: Co-Founder of Ginkgo Bioworks and founder of 1 other company.
Jason Kelly: Co-Founder & CEO of Ginkgo Bioworks and founder of 1 other company.
Contact Info: 1 email address

View details of Ginkgo Bioworks's Founder profiles and Board Members

Ginkgo Bioworks' employee count trend

Ginkgo Bioworks has 638 employees as of Mar 26. Here is Ginkgo Bioworks's employee count trend over the years:

Employee count trend for Ginkgo Bioworks

Uncover Ginkgo Bioworks' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ginkgo Bioworks include Indigo, Syngenta and Spark Therapeutics. Here is the list of Top 10 competitors of Ginkgo Bioworks, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Allen & Company, Owl Rock & 53 others	81/100
2nd	Indigo 2013, Boston (United States), Series G	Provider of biological and sustainability solutions for the agriculture industry	$1.4B	Flagship Pioneering, Baillie Gifford & 26 others	78/100
3rd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
4th	Spark Therapeutics 2013, Philadelphia (United States), Acquired	Developer of gene therapy for rare diseases	$82.8M	Sofinnova Investments, Brookside Capital & 6 others	73/100
5th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Fidelity Investments & 39 others	72/100
6th	Beam Therapeutics 2017, Cambridge (United States), Public	Developer of gene therapy using CRISPR base editing to treat diseases	$222M	Redmile Group, Cormorant-asset & 16 others	70/100
7th	Passage Bio 2017, Philadelphia (United States), Public	Developer of gene therapies for CNS rare diseases	$226M	Access Biotechnology, Orbimed & 10 others	69/100
8th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	Vivo Capital, Malaysian Life Sciences Capital Fund ... & 12 others	68/100
9th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
10th	Kula Bio 2018, Natick (United States), Series A	Manufacturer of microbial crop nutrition products	$86.7M	Collab Fund, Lowercarbon Capital & 16 others	67/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Ginkgo Bioworks's competitors? Click here to see the top ones

Ginkgo Bioworks has made 5 investments in companies including Phytolon and BiomEdit. Ginkgo Bioworks has also acquired 12 companies including Patch and Proof Diagnostics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 28, 2024	Acquisition	Patch	2020	New York City (United States)
Feb 28, 2024	Acquisition	Proof Diagnostics	2020	Cambridge (United States)
Feb 28, 2024	Acquisition	Reverie Labs	2017	Boston (United States)